Skip to main content
Publications
Rothman KJ , Huisman M, Lip G, Diener H, Dubner S, Ma C, Zint C, Teutsch C, Shoof N, Paquette M, Kleine E, Bartels D, Halperin J, the GLORIA AT study team . Use of propensity scores to assess comparability of treatment groups in a registry program . Presented at the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; October 25, 2014. Taipei, Taiwan.
Mines D , Tennis P, Curkendall SM, Li DK, Peterson C, Andrews EB, Calingaert B , Chen H, Deshpande G, Esposito DB, Everage N, Holick CN, Meyer NM, Nkhoma ET, Quinn S, Rothman KJ , Chan KA. Topiramate use in pregnancy and the birth prevalence of oral clefts . Pharmacoepidemiol Drug Saf. 2014 Oct 1;23(10):1017-25. doi: 10.1002/pds.3612
Long A, Rahmaoui A, Rothman KJ , Guinan E, Eisner M, Bradley MS, Iribarren C, Chen H, Carrigan G, Rosén K, Szefler S. Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab . J Allergy Clin Immunol Pract. 2014 Sep;134(3):560-567.e. doi: 10.1016/j.jaci.2014.02.007
Vinceti M, Malagoli C, Rothman KJ , Rodolfi R, Astolfi G, Calzolari E, Puccini A, Bertolotti M, Lunt M, Paterlini L, Martini M, Nicolini F. Risk of birth defects associated with maternal pregestational diabetes . Eur J Epidemiol. 2014 Jun;29(6):411-8.
Kaye JA, Castellsague J, Bui CL , Calingaert B , McQuay LJ, Riera-Guardia N , Saltus CW , Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ , Wallander M-A, Perez-Gutthann S . Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study . Pharmacotherapy. 2014 Apr;34(4):336-49. doi: 10.1002/phar.1367
Cole JA, Elbert A, Haas J, Hewitt K, Bertagna Leavy M, Marshall BC, Rothman KJ , Tarver M. Modifying and Stopping Registries. In: Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for evaluating patient outcomes: a user's guide . 3rd edition ed. Rockville: MD. Agency for Healthcare Research and Quality; 2014.
Huisman MV, Lip GY, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ , Teutsch C, Zint K, Ackermann D, Clemens A, Bartels DB. Design and rationale of global registry on long-term oral antithrombotic treatment in patients with atrial fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation . Am Heart J. 2014 Mar;167(3):329-34. doi: 10.1016/j.ahj.2013.12.006
Bui CL , Kaye JA, Castellsague J, Calingaert B , McQuay LJ, Riera-Guardia N , Saltus CW , Quinlan SC, Holick CN, Wahl PM, Suzart K, Rothman KJ , Wallander MA, Perez-Gutthann S . Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial users . Curr Drug Saf. 2014 Mar;9(1):23-8.
Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EVJr, Ananthakrishnan AN, Nguyen GC, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ , Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States . Inflamm Bowel Dis. 2014 Feb;20(2):398-415. doi: 10.1097/01.MIB.0000435441.30107.8b
Rothman KJ . Persons at high risk of cancer. An approach to cancer etiology and control. In: Fraumeni J Jr, editor, editors. Alcohol . New York: NY. Academic Press; 1975.